MALDI-MS has also been used to identify increased levels of proprotein convertase 1 inhibitor (ProSAAS) in FTD CSF (Davidsson et al., 2002) and potentially pathologically involved ProSAAS N-terminal fragments in the temporal lobe of FTD samples (Kikuchi et al., 2003). Here, PCSK1N is linked to frontotemporal dementia.